Rechercher des projets européens

18 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

REgenerative Stem cell therapy for STroke in Europe (RESSTORE)

Date du début: 1 sept. 2015, Date de fin: 31 août 2020,

...g preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life. RESSTORE European multicentre randomised phase IIb will explore, for the first time, the efficacy (functional recovery) and safety of intravenous infusion of allogenic adipose tissue derived mesenchymal stem cells (ADMSCs) ...
Voir le projet

 29

 TERMINÉ 

European Prevention of Alzheimer’s Dementia Consortium (EPAD)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,

Background:The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical trial, of the highest quality, testing multiple interventions. To achieve this, EPAD will also provide the analytical infras ...
Voir le projet

 40

 TERMINÉ 
The current healthcare systems are built around the traditional paradigm of patients suffering from a single acute illness. They are therefore largely unprepared to face the increasing demands for health services arising from the expansion of an older population with specific medical needs related to multiple chronic disorders. As a consequence, the medical conditions of a large and growing seg ...
Voir le projet

 27

 TERMINÉ 
"The dramatic differentials in healthy ageing, quality of life and life expectancy between individuals of different socioeconomic groups, is a major societal challenge facing Europe. The overarching aim of the LIFEPATH project is to understand the determinants of diverging ageing pathways among individuals belonging to different socio-economic groups. This will be achieved via an original study de ...
Voir le projet

 18

 TERMINÉ 
...(ASCs) are attractive for cellular therapy given the abundance of tissue, high frequency of MSCs and minimally invasive harvest procedure. The EU consortium ADIPOA has shown in a ‘first in man’ 2-centre Phase I safety study that intraarticular injection of a single dose of autologous ASCs to the knee (18 patients, 12 month follow-up) was well-tolerated, had no adverse effects, and resulted in an i ...
Voir le projet

 20

 TERMINÉ 
Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single most important, preventable cause of brain damage. European ID is due to significant heterogeneity in prevention and monito ...
Voir le projet

 33

 TERMINÉ 
The forecasted increase in the number of older people for this century will be accompanied by an increase of those with disabilities. Disability is usually preceded by a condition named frailty that encompasses changes associated with ageing, life styles and chronic diseases. To detect and intervene on it is of outstanding importance to prevent disability, as recovery from disability is unlikely. ...
Voir le projet

 29

 TERMINÉ 
...trategy, uses the synergy resulting from applying 2 vaccine candidates in 2 complementary indications linked through their pathology. TANDEM PD/MSA capitalizes on (i) excellent clinical research centres and their associated national/European networks, (ii) platform methods assessing aSyn species as candidate biomarkers and (iii) preliminary clinical experience with PD01A, the first aSyn targeting ...
Voir le projet

 8

 TERMINÉ 

VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial (DO-HEALTH)

Date du début: 1 janv. 2012, Date de fin: 30 juin 2017,

...a-3 fatty acids and physical exercise. However, their individual and combined effects have yet to be confirmed in a clinical trial. The DO-HEALTH will close this knowledge gap in a large 3-year multi-centre clinical trial that will establish long-term efficacy and safety data for the 3 interventions in the prevention of age-related diseases in seniors.The DO-HEALTH trial will enrol 2152 community- ...
Voir le projet

 25

 TERMINÉ 
The prevalence of diabetes in people ≥ 65 years approaches 25% (40% of all patients with diabetes are > 65 years). This number will increase 4-fold in people > 70 years in 2050. Diabetes results in a high personal and social health burden, and a significant public health burden in terms of rising healthcare costs. Diabetes is associated with increased functional decline in older people and may exp ...
Voir le projet

 17

 TERMINÉ 
Disorders of sex development (DSD) are a conglomerate of rare diseases with an estimated incidence of 1: 4500. The causes of DSD are mainly disorders with gonadal dysgenesis, decreased androgen synthesis or function in XY males or disorders with elevated androgen production in XX females. Decision on sex of rearing is difficult in some cases as the prenatal androgen imbalances result in ambiguous ...
Voir le projet

 17

 TERMINÉ 

PROMOTE PHYSICAL EXERCISE IN FRAIL ELDERLY

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2016,

VIVIfy is born to support European health systems handle the challenges of efficient care provision and system reorganisation, and meet future needs, related to an ageing and frailty society, through the search for formulas that improve quality of life, putting in value the positive effects of sport and exercise programmes. Establishing synergies among sport, health, social care, and education sys ...
Voir le projet

 7

 TERMINÉ 

Best EScalation Treatment in Multiple Sclerosis (MS) (BEST MS)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,

"Multiple Sclerosis (MS) is a devastating disease of the central nervous system affecting 2.5 million worldwide. MS is a field of constant therapeutic innovation, a fact which brings hope to young adults since MS is one of the most frequent causes of severe handicap. A major unmet need is to rationalize treatment decisions. To date, there is no way of predicting which patients will best respond to ...
Voir le projet

 5

 TERMINÉ 
... Pyrénées Limousin,Instituto Aragonés de Ciencias de la Salud (IACS), Université Paul Sabatier de Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU), Fundación Vasca de Innovación e Investigación Sanitarias (BIOEF), Centro de Investigación Biomédica de La Rioja (CIBIR) e Instituto de Investigación Biosanitaria (BIODONOSTIA).
Voir le projet

 8

 TERMINÉ 
Given the increasing number of patients/consumers with dementia, political action is urgently required to prepare the health care services throughout Europe to deliver cost effective high quality long-term care to people concerned. Currently there is a lack of clinical research data of patients/consumers and informal caregivers to develop best practice strategies for long-term care. RightTimePlace ...
Voir le projet

 8

 TERMINÉ 
DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment), aims at creating a e-Infrastructure to enhance the diagnostic confidence in chronic brain diseases such as Alzheimer and dementia. Proper management of these neurodegenerative diseases are thought to be very important in terms of health-economical point of view. The DECIDE infrastructure will provide the med ...
Voir le projet

 13

 TERMINÉ 
The e-MEDICINimage project enabled the creation of a remote continuing education scheme in the health sector (medical biology) related to parasitology and medical mycology. These two training schemes are built exclusively on e-Learning techniques and each of them offers a unique curriculum available in 5 languages (English, Spanish, French, Polish and Portuguese). This scheme, associated with the ...
Voir le projet

 16

 TERMINÉ 
Le projet a pour but de rapprocher la Communauté médicale de la Clinique Universitaire de Navarre, de celle de lHopital Rangueil du CHU de Toulouse. Il sinscrit dans le cadre des liens forts de coopération déja tissés entre les deux partenaires parmi lesquels peut etre cité le projet de recherche sur la Thérapie Cellulaire qui a été accepté en 2002. Il permettra un meilleur suivi sur cette recherc ...
Voir le projet

 2